Overview
Smart money at a glance
Filings to Oct 12, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 0 added, 5 cutMore cutting
Market overview
Fundamentals Jun 16- 52-wk high
- $24.85
- 52-wk low
- $22.72
- Mkt cap
- $1.28B
- P/E
- 19.6x
- Fwd P/E
- 16.9x
- Beta
- 0.04
- P/S
- 1.2x
- P/B
- 1.0x
- Profit margin
- +5.9%
- Op margin
- +6.6%
- ROE
- +5.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about PRA filings
Are insiders buying or selling ProAssurance Corporation (PRA) stock?
Neither. ProAssurance Corporation (PRA) insiders filed no open-market purchases or sales in the 90 days to Oct 12, 2026, according to SEC Form 4 filings.
Which members of Congress have traded PRA recently?
None. No member of Congress disclosed a PRA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this PRA smart-money data?
This summary uses filings available on Oct 12, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Sells/Trims (3)
- QR

Qube Research
$29.6M
sold
- MI

Millennium
$26.8M
sold
- TA

Third Avenue
$6.4M
sold
How top traders are positioned
No tracked top-trader positions in PRA right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No earnings history.
What the street expects next
Financials
Is the business strong?
Fairly priced and running thin margins.
- Net margin
- 5.9%
- P/E
- 19.62
- Forward P/E
- 16.86
- Market cap
- $1.3B
Valuation
- P/S1.17
- P/B0.95
Quality
- Operating margin6.6%
- ROE5.1%
- ROA1.5%
Growth
- Beta0.04
Technicals
Price structure
Market data unavailable.